Tom Venken
Tom Venken
researcher, VIB
Verified email at kuleuven.be
TitleCited byYear
A novel method for hydrophobin extraction using CO 2 foam fractionation system
M Khalesi, T Venken, S Deckers, J Winterburn, Z Shokribousjein, ...
Industrial Crops and Products 43, 372-377, 2013
342013
An optimized MM/PBSA virtual screening approach applied to an HIV‐1 gp41 fusion peptide inhibitor
T Venken, D Krnavek, J Münch, F Kirchhoff, P Henklein, M De Maeyer, ...
Proteins: Structure, Function, and Bioinformatics 79 (11), 3221-3235, 2011
302011
Combined Modeling and Biophysical Characterisation of CO2 Interaction with Class II Hydrophobins: New Insight into the Mechanism Underpinning Primary Gushing
S Deckers, T Venken, M Khalesi, K Gebruers, Y Lorgouilloux, ...
Journal of the American Society of Brewing Chemists 70 (4), 249-256, 2012
222012
Identification of a Small Molecule That Modulates Platelet Glycoprotein Ib-von Willebrand Factor Interaction
K Broos, M Trekels, RA Jose, J Demeulemeester, A Vandenbulcke, ...
Journal of Biological Chemistry 287 (12), 9461-9472, 2012
182012
Mapping the Binding Interface between an HIV-1 Inhibiting Intrabody and the Viral Protein Rev
T Vercruysse, E Boons, T Venken, E Vanstreels, A Voet, J Steyaert, ...
PloS one 8 (4), e60259, 2013
162013
pKa Modulation of the Acid/Base Catalyst within GH32 and GH68: A Role in Substrate/Inhibitor Specificity?
S Yuan, K Le Roy, T Venken, W Lammens, W Van den Ende, ...
PloS one 7 (5), e37453, 2012
112012
Computational investigation of the HIV‐1 Rev multimerization using molecular dynamics simulations and binding free energy calculations
T Venken, D Daelemans, M De Maeyer, A Voet
Proteins: Structure, Function, and Bioinformatics 80 (6), 1633-1646, 2012
92012
Rapid conformational fluctuations of disordered HIV-1 fusion peptide in solution
T Venken, A Voet, M De Maeyer, G De Fabritiis, SK Sadiq
Journal of Chemical Theory and Computation 9 (7), 2870-2874, 2013
82013
Interactions stabilizing the C-terminal helix of human phospholipid scramblase 1 in lipid bilayers: A computational study
T Venken, AS Schillinger, E Fuglebakk, N Reuter
Biochimica et Biophysica Acta (BBA)-Biomembranes 1859 (7), 1200-1210, 2017
52017
d-Peptides as inhibitors of PR3-membrane interactions
K Maximova, T Venken, N Reuter, J Trylska
Biochimica et Biophysica Acta (BBA)-Biomembranes 1860 (2), 458-466, 2018
32018
Thermodynamic framework to assess low abundance DNA mutation detection by hybridization
H Willems, A Jacobs, WW Hadiwikarta, T Venken, D Valkenborg, ...
PloS one 12 (5), e0177384, 2017
32017
Computational Studies of the Active and Inactive Regulatory Domains of Response Regulator PhoP Using Molecular Dynamics Simulations
XY Qing, H Steenackers, T Venken, M De Maeyer, A Voet
Molecular informatics 36 (11), 1700031, 2017
22017
Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization
HN Wood, T Venken, H Willems, A Jacobs, AJ Reis, PEA da Silva, ...
PloS one 14 (2), e0212064, 2019
12019
Combined Modeling and Biophysical Characterisation of CO2 Interaction with Class II Hydrophobins: New Insight into the Mechanism Underpinning Primary Gushing
SM Deckers, T Venken, M Khalesi, K Gebruers, G Baggerman, ...
Cerevisia 2 (38), 58, 2013
12013
Enhancing the performance of DNA surface-hybridization biosensors through target depletion
SK Nomidis, M Szymonik, T Venken, E Carlon, J Hooyberghs
Langmuir 35 (37), 12276-12283, 2019
2019
D-peptides as inhibitors of Proteinase 3-membrane interactions
K Maximova, T Venken, N Reuter, J Trylska
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017
2017
Investigating the Interaction of the Putative Transmembrane Domain of Human Phospholipid Scramblase with Lipid Bilayers using Molecular Dynamics Simulations
T Venken, AS Schillinger, E Fuglebakk, N Reuter
Biophysical Journal 110 (3), 80a, 2016
2016
Computational study of HIV gp41 FP and Rev as novel antiretroviral targets
T Venken
2013
The system can't perform the operation now. Try again later.
Articles 1–18